Product image of Linezolid Kabi (Linezolid) supplied by GNH India

Linezolid Kabi

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Kabi (Linezolid)

Linezolid, the active ingredient in Linezolid Kabi, is an oxazolidinone antibiotic presented as an intravenous solution for intravenous use. Approved in the European Union, it treats complicated skin and soft tissue infections, community‑acquired and nosocomial pneumonia, as well as infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE) in adult patients.

GNH India supplies Linezolid Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with full regulatory documentation and quality assurance.

Manufacturer / TM Owner

Fresenius Kabi Polska Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Linezolid is an oxazolidinone antibiotic used to treat serious bacterial infections.
  • Complicated skin and soft tissue infections: reduces bacterial load and promotes healing in infections caused by susceptible Gram‑positive organisms.
  • Community‑acquired and nosocomial pneumonia: improves respiratory outcomes by targeting resistant Streptococcus pneumoniae and Staphylococcus aureus.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides bacteriostatic activity against MRSA strains in various infection sites.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative treatment option for VRE‑related infections.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby blocking translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations, leading to suppression of bacterial growth. The binding site is distinct from that of other antibiotic classes, reducing cross‑resistance, and the effect persists throughout the dosing interval.

Side Effects

Linezolid may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional stomach upset with emesis.
  • Rash: mild skin erythema.
  • Elevated liver enzymes: transient increase in hepatic transaminases.
  • Thrombocytopenia: mild reduction in platelet count.

Serious or Rare Side Effects

  • Myelosuppression: severe decrease in blood cell production.
  • Peripheral neuropathy: sensory nerve damage with prolonged use.
  • Lactic acidosis: rare metabolic disturbance that can be life‑threatening.
  • Serotonin syndrome: risk when combined with serotonergic agents.

Precautions & Warnings

When prescribing Linezolid, clinicians should consider several safety and handling precautions.

  • Renal impairment: adjust monitoring as drug is primarily excreted unchanged.
  • Hepatic dysfunction: observe liver function tests during therapy.
  • Hematologic monitoring: check complete blood count for thrombocytopenia or anemia.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Prolonged therapy: limit duration to reduce risk of peripheral neuropathy.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Linezolid interacts with several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs), serotonin‑norepinephrine reuptake inhibitors (SNRIs) and tricyclic antidepressants: risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis.
  • Rifampicin: reduces linezolid plasma concentrations, compromising efficacy.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, monitor INR.
  • Ethanol: may increase risk of disulfiram‑like reaction.
  • Anticonvulsants (e.g., carbamazepine, phenytoin): may lower linezolid levels.

Frequently Asked Questions

Linezolid Kabi is an intravenous oxazolidinone antibiotic indicated for the treatment of complicated skin and soft tissue infections, community‑acquired and nosocomial pneumonia, as well as infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE) in adult patients.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the formation of the initiation complex required for translation. This prevents bacterial growth and, at higher concentrations, can be bactericidal against susceptible organisms.

The dosing regimen for Linezolid Kabi is determined by the prescribing clinician based on the infection type, severity, renal and hepatic function, and patient-specific factors. Exact dosage and duration should follow the prescriber’s order and local guidelines.

Safety data for Linezolid in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Linezolid Kabi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Linezolid offers activity against Gram‑positive pathogens, including MRSA and VRE, where vancomycin may be less effective against VRE. Unlike glycopeptides, linezolid is available in an intravenous formulation and has a distinct mechanism, reducing cross‑resistance, but it requires monitoring for hematologic toxicity.

Store Linezolid Kabi at ambient temperature, preferably below 25 °C, in its original packaging. Protect the solution from light, moisture, and extreme temperatures. Follow standard aseptic techniques when preparing the intravenous infusion.

Linezolid Kabi is administered by intravenous infusion. The solution is diluted in an appropriate compatible fluid and infused over a recommended period, typically 30‑60 minutes, according to the prescriber’s instructions and institutional protocols.

Serious adverse events include myelosuppression (especially thrombocytopenia and anemia), peripheral neuropathy with prolonged therapy, lactic acidosis, and serotonin syndrome when combined with serotonergic agents. Patients should be monitored regularly for blood counts, neurologic symptoms, and metabolic disturbances.

Linezolid Kabi should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones. Caution is advised in individuals taking serotonergic medications, MAO inhibitors, or those with pre‑existing severe hepatic impairment, as safety has not been established.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT